DE69714011D1 - Die erzeugung einer immunantwort gegen erwünschte determinanten - Google Patents

Die erzeugung einer immunantwort gegen erwünschte determinanten

Info

Publication number: DE69714011D1
Authority: DE; Germany
Prior art keywords: immune response; generation; determinants; desired determinants; provides compositions
Prior art date: 1996-01-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69714011T

Other languages

English (en)

Other versions

DE69714011T2 (de

Inventor

L Alexander

Shawn Defrees

Alessandro Sette

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Epimmune Inc

Original Assignee

Epimmune Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-24

Filing date

1997-01-23

Publication date

2002-08-22

1997-01-23 Application filed by Epimmune Inc filed Critical Epimmune Inc

2002-08-22 Publication of DE69714011D1 publication Critical patent/DE69714011D1/de

2003-02-27 Application granted granted Critical

2003-02-27 Publication of DE69714011T2 publication Critical patent/DE69714011T2/de

2017-01-24 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Microbiology (AREA)
Virology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Compounds Of Unknown Constitution (AREA)
Medicines Containing Plant Substances (AREA)
Steroid Compounds (AREA)
Control Of High-Frequency Heating Circuits (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE69714011T 1996-01-24 1997-01-23 Die erzeugung einer immunantwort gegen erwünschte determinanten Expired - Lifetime DE69714011T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1051096P	1996-01-24	1996-01-24
PCT/US1997/001041 WO1997026784A1 (en)	1996-01-24	1997-01-23	Induction of immune response against desired determinants

Publications (2)

Publication Number	Publication Date
DE69714011D1 true DE69714011D1 (de)	2002-08-22
DE69714011T2 DE69714011T2 (de)	2003-02-27

Family

ID=21746084

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69714011T Expired - Lifetime DE69714011T2 (de)	1996-01-24	1997-01-23	Die erzeugung einer immunantwort gegen erwünschte determinanten

Country Status (12)

Country	Link
EP (1)	EP0876398B1 (de)
JP (1)	JP4063879B2 (de)
CN (1)	CN1214051A (de)
AT (1)	ATE220687T1 (de)
AU (1)	AU1582797A (de)
BR (1)	BR9710404A (de)
CA (1)	CA2242878C (de)
DE (1)	DE69714011T2 (de)
DK (1)	DK0876398T3 (de)
ES (1)	ES2177927T3 (de)
PT (1)	PT876398E (de)
WO (1)	WO1997026784A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6528061B1 (en) *	1997-09-04	2003-03-04	Pasteur Institut	Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
EP1903056A3 (de)	2002-12-10	2008-05-07	Idm Pharma, Inc.	HLA-A1, -A2, -A3, -A24, -B7 and -B44 bindende Peptide die Tumorassoziiert-Antigen Epitopen enthalten, und Zusammensetzungen davon
EP1572740A2 (de) *	2002-12-11	2005-09-14	Pharmexa A/S	Zielgerichteten einzigen epitopen
ES2456666T3 (es)	2003-04-18	2014-04-23	Biotech Synergy, Inc.	Péptidos antígenos HLA-A2 asociados a un tumor y composiciones
ES2310072B1 (es)	2005-12-23	2009-11-16	Proyecto De Biomedicina Cima, S.L.	Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
WO2009025777A1 (en) *	2007-08-17	2009-02-26	University Of Maryland	Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
EP2391635B1 (de) *	2009-01-28	2017-04-26	Epimmune Inc.	Pan-dr-bindende polypeptide und verwendungen davon
WO2012123269A1 (en)	2011-03-11	2012-09-20	Proyecto De Biomedicina Cima, S.L.	Immunogenic compositions and methods for their use
US10588952B2 (en) *	2013-03-29	2020-03-17	Sumitomo Dainippon Pharma Co., Ltd.	Conjugate vaccine using trimming function of ERAP1
JP5885885B2 (ja)	2013-03-29	2016-03-16	大日本住友製薬株式会社	Ｗｔ１抗原ペプチドコンジュゲートワクチン
JP6692294B2 (ja)	2013-07-31	2020-05-13	バイオベンチャーズ・リミテッド・ライアビリティ・カンパニーＢｉｏＶｅｎｔｕｒｅｓ，ＬＬＣ	腫瘍関連糖鎖抗原を標的として癌を治療及び予防するための組成物及び方法
TW201622743A (zh) *	2014-03-19	2016-07-01	財團法人臺灣基督長老教會馬偕紀念社會事業基金會馬偕紀念醫院	免疫原醣肽、包含該醣肽之組合物及其用途
CN107141355B (zh) *	2017-05-31	2021-05-14	中国人民解放军第四军医大学	一种htnv抗原表位线性串联多肽及表位肽-复合物四聚体和应用
CN109991422A (zh) *	2017-12-29	2019-07-09	复旦大学	基于特异抗血清的棕榈酰化修饰蛋白质的检测方法
WO2021228853A1 (en)	2020-05-11	2021-11-18	Ose Immunotherapeutics	Vaccine against sars-cov virus
US20230134067A1 (en)	2020-07-22	2023-05-04	3H Bio. Co., Ltd.	A peptide used for immunotherapeutics
KR102261457B1 (ko) *	2020-07-22	2021-06-09	(주)쓰리에이치바이오	면역 치료제용 펩타이드
WO2022268916A2 (en)	2021-06-23	2022-12-29	Ose Immunotherapeutics	Pan-coronavirus peptide vaccine
WO2023197079A1 (en)	2022-04-14	2023-10-19	The Hospital For Sick Children	Pfcsp-based immunogens and related composition and methods
WO2025093541A1 (en)	2023-10-31	2025-05-08	Ose Immunotherapeutics	Combination of interleukin 7 and tumour associated antigen vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9406652A (pt) *	1993-03-05	1996-09-10	Cytel Corp	Composição
EP0735893B1 (de) *	1993-09-14	2008-11-26	Pharmexa Inc.	Pan dr-bindeproteinen zur erhöhung der immunantwort

1997
- 1997-01-23 CN CN97193221A patent/CN1214051A/zh active Pending
- 1997-01-23 DE DE69714011T patent/DE69714011T2/de not_active Expired - Lifetime
- 1997-01-23 JP JP52697997A patent/JP4063879B2/ja not_active Expired - Lifetime
- 1997-01-23 ES ES97902074T patent/ES2177927T3/es not_active Expired - Lifetime
- 1997-01-23 WO PCT/US1997/001041 patent/WO1997026784A1/en active IP Right Grant
- 1997-01-23 AT AT97902074T patent/ATE220687T1/de active
- 1997-01-23 DK DK97902074T patent/DK0876398T3/da active
- 1997-01-23 AU AU15827/97A patent/AU1582797A/en not_active Abandoned
- 1997-01-23 EP EP97902074A patent/EP0876398B1/de not_active Expired - Lifetime
- 1997-01-23 BR BR9710404A patent/BR9710404A/pt not_active IP Right Cessation
- 1997-01-23 PT PT97902074T patent/PT876398E/pt unknown
- 1997-01-23 CA CA2242878A patent/CA2242878C/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CN1214051A (zh)	1999-04-14
ES2177927T3 (es)	2002-12-16
DK0876398T3 (da)	2002-08-12
BR9710404A (pt)	1999-08-17
AU1582797A (en)	1997-08-20
EP0876398B1 (de)	2002-07-17
DE69714011T2 (de)	2003-02-27
ATE220687T1 (de)	2002-08-15
JP4063879B2 (ja)	2008-03-19
CA2242878C (en)	2010-06-22
CA2242878A1 (en)	1997-07-31
EP0876398A1 (de)	1998-11-11
PT876398E (pt)	2002-12-31
WO1997026784A1 (en)	1997-07-31
JP2000504328A (ja)	2000-04-11

Publication	Publication Date	Title
DE69714011D1 (de)	2002-08-22	Die erzeugung einer immunantwort gegen erwünschte determinanten
DE69929444D1 (de)	2006-04-06	Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
BR0313587A (pt)	2006-06-13	composições imunoestimuladoras e métodos de estimulação de uma resposta imune
DK0814836T3 (da)	2001-04-17	Vaccineadjuvanser
CY1108074T1 (el)	2014-02-12	Ανοσολογικες μεθοδοι για τη ρυθμιση της μυοστατινης σε σπονδυλωτα
PT966447E (pt)	2003-07-31	Moleculas pequenas uteis no tratamento de doencas inflamatorias
ATE397005T1 (de)	2008-06-15	Sialyl-lewisa und sialyl-lewisx epitope analoge
EP1594536A4 (de)	2006-09-06	Adjuvante influenza-vakzine
SG167667A1 (en)	2011-01-28	Nucleic acid compositions for stimulating immune responses
UY24654A1 (es)	2001-08-27	Composición de vacuna contra la malaria
NO964238L (no)	1996-10-04	Halofantrin-fri-base for behandling av malaria og blandinger
BG102623A (en)	1999-03-31	New derivatives of benzoylguanadine, methods for their preparation and application for the manufacture of medicamentous forms
ATE413888T1 (de)	2008-11-15	Salmonella vakzine
NO20001421L (no)	2000-05-19	T-cellevaksinasjon for behandling av multippel sklerose
DK1146906T3 (da)	2011-10-24	Mukosalt afgivelsessystem
DK0786004T3 (da)	2001-10-22	Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
TR200001102T2 (tr)	2000-08-21	İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ES2192610T3 (es)	2003-10-16	Aminouracilos substituidos.
ES2148572T3 (es)	2000-10-16	Derivados hidrosolubles de epipodofilotoxina, su procedimiento de preparacion, su utilizacion a titulo de medicamento, y su utilizacion destinada a los tratamientos anticancerosos.
ITRM920078A1 (it)	1993-08-05	Connettore elettrico e metodo per produrlo.
FR2715304B1 (fr)	1996-04-26	Vaccin anti-allergique.
DE69429521D1 (de)	2002-01-31	Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
ATE385809T1 (de)	2008-03-15	Saponin-zusammensetzungen und deren verwendung
DE60126490D1 (de)	2007-03-22	Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
ES2141923T3 (es)	2000-04-01	Uso hipocolesterolemico, antiaterosclerotico e hipotrigliceridemico de derivados aminoacetilmercapto.

Legal Events

Date	Code	Title	Description
2003-08-14	8364	No opposition during term of opposition